4//SEC Filing
Loiacono Michael 4
Accession 0001209191-23-014161
CIK 0001094038other
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 4:50 PM ET
Size
5.7 KB
Accession
0001209191-23-014161
Insider Transaction Report
Form 4
Loiacono Michael
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2023-02-27+38,480→ 38,480 totalExercise: $2.14Exp: 2033-02-27→ Common Stock (38,480 underlying)
Footnotes (1)
- [F1]This option vests in equal monthly installments over a four year period commencing on March 27, 2023 subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date.
Documents
Issuer
Marker Therapeutics, Inc.
CIK 0001094038
Entity typeother
Related Parties
1- filerCIK 0001679119
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 4:50 PM ET
- Size
- 5.7 KB